Richard V. McCloskey M.S., M.D.
|Age||Total Calculated Compensation||This person is connected to 25 board members in 2 different organizations across 5 different industries.|
See Board Relationships
Dr. Richard V. McCloskey, M.S., M.D., also known as Mac, has been Executive Vice President of Clinical Development at Renova Therapeutics, Inc. since January 2016. Dr. McCloskey serves as a Scientific Adviser at Synageva and an Adviser to Endo Pharmaceuticals. Dr. McCloskey served as the Vice President of Medical Technology at Johnson & Johnson Innovation - JJDC, Inc. Dr. McCloskey served in the liaison to academia and supports the transfer and discovery of biotechnology ...
410 George StreetPhone: 732-524-3218
New Brunswick, New Jersey 08901
Board Members Memberships*
University of Rochester
Washington & Jefferson College
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.